|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 231/56 | |
| A61K 31/416 | |||
| A61K 31/4192 | |||
| A61K 31/4745 | |||
| C07D 249/18 | |||
| C07D 471/04 | |||
| A61P 3/00 |
| (11) | Number of the document | 3126336 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15713528.6 |
| Date of filing the European patent application | 2015-04-02 | |
| (97) | Date of publication of the European application | 2017-02-08 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/057414 |
| Date | 2015-04-02 |
| (87) | Number | WO 2015/150564 |
| Date | 2015-10-08 |
| (30) | Number | Date | Country code |
| 14305494 | 2014-04-04 | EP |
| (72) |
SCHWINK, Lothar, DE
BUNING, Christian, DE
GLOMBIK, Heiner, DE
GOSSEL, Matthias, DE
KADEREIT, Dieter, DE
HALLAND, Nis, DE
LOHMANN, Matthias, DE
PÖVERLEIN, Christoph, DE
RITTER, Kurt, DE
|
| (73) |
SANOFI,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | SUBSTITUTED FUSED HETEROCYCLES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS |
| SUBSTITUTED FUSED HETEROCYCLES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS |